iRadimed's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
iRadimed (NASDAQ:IRMD) is set to release its latest quarterly earnings report on November 3, 2023. Analysts estimate an earnings per share (EPS) of $0.36. The company's past performance shows it beat EPS estimates last quarter, which led to a 0.46% increase in share price the next day. iRadimed's shares were trading at $41.06 as of November 1, with a 41.6% increase over the last 52-week period.
November 02, 2023 | 5:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
iRadimed is expected to report an EPS of $0.36 in its upcoming earnings. The company's stock price increased by 0.46% the day after it beat EPS estimates last quarter. The stock has seen a 41.6% increase over the last 52 weeks.
The upcoming earnings report is a significant event for iRadimed. If the company beats the EPS estimate as it did last quarter, it could lead to a short-term increase in the stock price. However, the actual impact will also depend on the company's guidance for the next quarter. The stock's performance over the last 52 weeks has been positive, which could be a good sign for long-term investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100